Union Minister launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.

ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024

Source: The post is based on the article “Union Minister launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine” published in PIB on 23rd June 2023

What is the News?

The Union Minister of Science and Technology has launched GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine.

What is GEMCOVAC-OM?

GEMCOVAC-OM is an indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus.

It is India’s first mRNA vaccine.

Developed by: Pune based Gennova Biopharmaceuticals with funding support from the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). 

Features: It is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines.

– It is delivered intra-dermally using a needle-free injection device system.

– It will for now only be available as a booster or “precaution dose”.

Print Friendly and PDF
Blog
Academy
Community